Journal of Lipid Research, Vol 23, 747-753, Copyright © 1982 by Lipid Research, Inc.

ARTICLES

Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II

MC Cheung and JJ Albers

High density lipoproteins (HDL) were subfractionated by equilibrium CsCl gradient centrifugation of the d 1.063-1.21 g/ml HDL fraction isolated from two men and two women. The various HDL subfractions were analyzed for their apoproteins (apo) A-I, A-II, B, D, and E and the major lipid contents. ApoA-I and A-II were found throughout the density gradient with the maximum concentration between the d 1.105 and 1.120 g/ml fractions. ApoE was found in all HDL fractions with the higher concentration in the lower density fractions. Conversely, the concentration of apoD increased as the density of the HDL fraction increased. Each density subfraction underwent quantitative precipitation with anti-A-I and anti-A-II immunoglobulin. Essentially all A-II in all density subfractions was precipitated with either immunoglobulin. Particles from each density subfraction precipitated with anti-A-II immunoglobulin had an A-I/A-II molar ratio of approximately 2.0 (range 1.9-2.3). However, particles precipitated with anti-A-I immunoglobulin had A-I/A-II molar ratios identical to the A- I/A-II ratio of the subfraction (range 2.1-7.1). The subfractions (d 1.105-1.149 g/ml fractions) with A-I/A-II molar ratios of about 2 had the least proportion of A-I in particles containing A-I but not A-II. Conversely, the subfractions (d 1.063-1.075 g/ml fractions) with the highest A-I/A-II molar ratio had the greatest proportion of apoA-I in particles containing A-I but not A-II. These data indicate that HDL contains at least two types of particles: particles with both A-I and A- II in a 2:1 molar ratio, and particles containing A-I but no A-II. The variation in A-I/A-II ratio observed in different HDL density subfractions was due to the different proportions of these two types of particles.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Movva and D. J. Rader Laboratory Assessment of HDL Heterogeneity and Function Clin. Chem., May 1, 2008; 54(5): 788 - 800. [Abstract] [Full Text] [PDF]

				E. M. M. Ooi, G. F. Watts, P. J. Nestel, D. Sviridov, A. Hoang, and P. H. R. Barrett Dose-Dependent Regulation of High-Density Lipoprotein Metabolism with Rosuvastatin in the Metabolic Syndrome J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 430 - 437. [Abstract] [Full Text] [PDF]

				A. Kontush, P. Therond, A. Zerrad, M. Couturier, A. Negre-Salvayre, J. A. de Souza, S. Chantepie, and M. J. Chapman Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles: Relevance to Antiapoptotic and Antioxidative Activities Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1843 - 1849. [Abstract] [Full Text] [PDF]

				U. C. Broedl, W. Jin, I. V. Fuki, J. S. Millar, and D. J. Rader Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II J. Lipid Res., October 1, 2006; 47(10): 2191 - 2197. [Abstract] [Full Text] [PDF]

				P. H. R. Barrett, D. C. Chan, and G. F. Watts Thematic review series: Patient-Oriented Research. Design and analysis of lipoprotein tracer kinetics studies in humans J. Lipid Res., August 1, 2006; 47(8): 1607 - 1619. [Abstract] [Full Text] [PDF]

				J. Ji, G. F. Watts, A. G. Johnson, D. C. Chan, E. M. M. Ooi, K.-A. Rye, A. P. Serone, and P. H. R. Barrett High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 973 - 979. [Abstract] [Full Text] [PDF]

				K.-A. Rye and P. J. Barter Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 421 - 428. [Abstract] [Full Text]

				K. W. Huggins, P. L. Colvin, E. R. Burleson, K. Kelley, J. K. Sawyer, P. H. R. Barrett, L. L. Rudel, and J. S. Parks Dietary n-3 polyunsaturated fat increases the fractional catabolic rate of medium-sized HDL particles in African green monkeys J. Lipid Res., September 1, 2001; 42(9): 1457 - 1466. [Abstract] [Full Text] [PDF]

				L.-C. Lyu, C.-Y. Yeh, A. H Lichtenstein, Z. Li, J. M Ordovas, and E. J Schaefer Association of sex, adiposity, and diet with HDL subclasses in middle-aged Chinese Am. J. Clinical Nutrition, July 1, 2001; 74(1): 64 - 71. [Abstract] [Full Text] [PDF]

				M. A. Deeg, E. L. Bierman, and M. C. Cheung GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex J. Lipid Res., March 1, 2001; 42(3): 442 - 451. [Abstract] [Full Text]

				P. L. Colvin, E. Moriguchi, P. H. R. Barrett, J. S. Parks, and L. L. Rudel Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates J. Lipid Res., October 1, 1999; 40(10): 1782 - 1792. [Abstract] [Full Text]

				D. L. Rainwater, L. Almasy, J. Blangero, S. A. Cole, J. L. VandeBerg, J. W. MacCluer, and J. E. Hixson A Genome Search Identifies Major Quantitative Trait Loci on Human Chromosomes 3 and 4 That Influence Cholesterol Concentrations in Small LDL Particles Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 777 - 783. [Abstract] [Full Text] [PDF]

				P. Colvin, E. Moriguchi, H. Barrett, J. Parks, and L. Rudel Production rate determines plasma concentration of large high density lipoprotein in non-human primates J. Lipid Res., October 1, 1998; 39(10): 2076 - 2085. [Abstract] [Full Text]

				P. J. Pussinen, M. Jauhiainen, J. Metso, L. E. Pyle, Y. L. Marcel, N. H. Fidge, and C. Ehnholm Binding of phospholipid transfer protein (PLTP) to apolipoproteins A-I and A-II: location of a PLTP binding domain in the amino terminal region of apoA-I J. Lipid Res., January 1, 1998; 39(1): 152 - 161. [Abstract] [Full Text]

				M. Tilly-Kiesi, A. H. Lichtenstein, J. Joven, E. Vilella, M. C. Cheung, W. V. Carrasco, J. M. Ordovas, G. Dolnikowski, and E. J. Schaefer Impact of Gender on the Metabolism of Apolipoprotein A-I in HDL Subclasses LpAI and LpAI:AII in Older Subjects Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3513 - 3518. [Abstract] [Full Text]

				M. Tilly-Kiesi, A. H. Lichtenstein, J. M. Ordovas, G. Dolnikowski, R. Malmstrom, M.-R. Taskinen, and E. J. Schaefer Subjects With ApoA-I(Lys107->0) Exhibit Enhanced Fractional Catabolic Rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI With AII) Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 873 - 880. [Abstract] [Full Text]

				M. Tilly-Kiesi, Z. Qiuping, S. Ehnholm, J. Kahri, S. Lahdenpera, C. Ehnholm, and M.-R. Taskinen ApoA-IHelsinki (Lys107->0) Associated With Reduced HDL Cholesterol and LpA-I:A-II Deficiency Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1294 - 1306. [Abstract] [Full Text]

				M. Tilly-Kiesi, S. P. Mattila, and M. J. Tikkanen Effects of Lovastatin on High-Density Lipoprotein Subfractions in Hypercholesterolemic Patients with Peripheral Vascular Disease Angiology, February 1, 1993; 44(2): 129 - 137. [Abstract] [PDF]